title: Response of refractory osteosarcoma to thalidomide and celecoxib.
authors.affiliation: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: Yu-Chieh
authors.initials: YC
authors.lastname: Tsai
authors.forename: Chen-Tu
authors.initials: CT
authors.lastname: Wu
authors.forename: Ruey-Long
authors.initials: RL
authors.lastname: Hong
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D000068579:Celecoxib; D019008:Drug Resistance, Neoplasm; D004359:Drug Therapy, Combination; D006615:Hip / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D012516:Osteosarcoma / Q000188:drug therapy* / Q000473:pathology*; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D011720:Pyrazoles; D013449:Sulfonamides; D013792:Thalidomide; D000068579:Celecoxib